Most of previous studies have confirmed the independent prognostic role of preoperative CA19-9 in CRC, and suggested CA19-9 an additional marker to determine the prognosis of CRC patients without elevated preoperative CEA [11, 17, 27], which were concordant with our conclusion. The gene discussed is CEACAM5; the disease is colorectal carcinoma.